Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literature

被引:0
|
作者
Manzo, Ciro [1 ]
Isetta, Marco [2 ]
Castagna, Alberto [3 ]
机构
[1] Azienda Sanit Locale Napoli 3 Sud, Rheumatol Outpatient Clin, Dept Internal & Geriatr Med, Hlth Dist 59, Naples, Italy
[2] Cent & North West London NHS Trust, London, England
[3] Azienda Sanit Provinciale Catanzaro, Dept Primary Care Hlth Dist Soverato, Catanzaro, Italy
来源
REUMATOLOGIA | 2024年 / 62卷 / 05期
关键词
polymyalgia rheumatica; narrative review; infectious agents; GIANT-CELL ARTERITIS; LYME-DISEASE; MANIFESTATIONS; VIRUS; ASSOCIATION; PNEUMONIAE; DIAGNOSIS; PATTERN; ONSET; RISK;
D O I
10.5114/reum/194687
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The aetiology of polymyalgia rheumatica (PMR) is unknown. Recently, reports on cases of PMR following the coronavirus disease 2019 (COVID-19) have revived the role of infection as an aetiological or triggering factor. It is estimated that patients with PMR have manifestations of giant cell arteritis (GCA) in < 20% of cases. To date, little is known on the potential role of infectious agents in facilitating this association. Given this background, we performed a review of published literature. Our first aim was to review and discuss the relationship between PMR and infective agents. Secondly, we compared data of PMR-only patients with PMR and overlapping GCA to seek any commonalities or differences regarding the type of infectious agent in these two subgroups. Material and methods: We performed a non-systematic literature search on Embase and Medline (COVID interface) with the following search terms: "polymyalgia rheumatica" AND "infections" OR "infectious agents", both MESH headings and free-text (in each language they were written). Each paper's reference list was scanned for additional publications meeting this study's aim. When papers reported data partially presented in previous articles, we referred to the most recent published data. Abstracts submitted at conferences or from non-peer-reviewed sources were not included. Polymyalgia rheumatica following vaccinations was an additional exclusion criterion. Results: Several infectious agents have been held responsible for PMR. However, no definite causal link has been identified so far. According to our review, the search for a specific infectious agent, however intriguing, appears to be stagnating. Genetic background and epigenetic regulation probably play a key role. However, topical studies are lacking. Polymyalgia rheumatica as an adverse event following immunization should be kept methodologically distinct from PMR following an acute infection, as the adjuvants in the vaccine can make a significant difference. Conclusions: Finally, some infectious agents are able to replicate in human arteries or have an endothelium tropism. Whilst these can theoretically trigger GCA, their role in isolated PMR seems minimal.
引用
收藏
页码:360 / 367
页数:8
相关论文
共 3 条
  • [1] Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature
    Manzo, Ciro
    Castagna, Alberto
    Isetta, Marco
    REUMATOLOGIA, 2022, 60 (02): : 142 - 147
  • [2] Feasibility and usefulness of a fast-track clinic for patients suspected of polymyalgia rheumatica: notes for a work schedule through a narrative review of published literature
    Hysa, Elvis
    Ghorbannia, Ali
    Emamifar, Amir
    Milchert, Marcin
    Manzo, Ciro
    REUMATOLOGIA, 2021, 59 (05): : 323 - 329
  • [3] Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms
    Hysa, Elvis
    Casabella, Andrea
    Gotelli, Emanuele
    Campitiello, Rosanna
    Schenone, Carlotta
    Genova, Carlo
    Tanda, Enrica Teresa
    Sulli, Alberto
    Smith, Vanessa
    Cimmino, Marco Amedeo
    Paolino, Sabrina
    Cutolo, Maurizio
    AUTOIMMUNITY REVIEWS, 2024, 23 (7-8)